Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
PaperCitations, authors & open-access status
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 260 citations, 2018 year and bronze oa status.
260
Citations
2018
Year
bronze
OA Status